Skip to main content
. 2016 Sep 14;11(9):e0162898. doi: 10.1371/journal.pone.0162898

Table 2. Adjusted odds ratio and 95% confidence intervals of depressive symptoms with sarcopenia and obesity status in the Kashiwa study.

Sarcopenia Non-sarcopenia
+ Obesity - Obesity + Obesity - Obesitya
OR (95% CI) p OR (95% CI) p OR (95% CI) P OR
Model 1 3.63 (1.96–6.71) <.001 1.23 (0.75–2.00) 0.41 1.39 (0.92–2.11) 0.12 -
Model 2 2.99 (1.58–5.65) <.001 0.96 (0.58–1.59) 0.87 1.30 (0.85–1.97) 0.14 -
Model 3 3.03 (1.57–5.86) 0.001 0.96 (0.56–1.63) 0.87 1.34 (0.87–2.06) 0.19 -
Model 4 2.79 (1.43–5.43) 0.003 0.93 (0.55–1.60) 0.80 1.23 (0.79–1.91) 0.36 -
Model 4a 1.77 (0.75–4.18) 0.20 0.73 (0.35–1.54) 0.41 1.13 (0.55–2.33) 0.75 -
Model 4b 6.05 (1.89–19.38) 0.003 1.36 (0.63–2.93) 0.44 1.28 (0.72–2.26) 0.40 -

a Non-sarcopenia/Non-obesity group is a reference group.

Abbreviations: OR, odds ratio; CI, confidence interval

Model 1: adjusted for age and sex

Model 2: adjusted for age, sex, food intake, poor sleep, and physical activity

Model 3: adjusted for age, sex, food intake, poor sleep, physical activity, education level, social isolation, living alone, and neighborhood ties

Model 4: adjusted for age, sex, food intake, poor sleep, physical activity, education level, social isolation, living alone, neighborhood ties, chronic comorbidity burden, use of antidepressant, and use of statin

Model 4a: adjusted for the same covariates as in Model 4, restricted to those aged 75 or over

Model 4b: adjusted for the same covariates as in Model 4, restricted to those aged 65 to 74